| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Laboratory of HealthCare Associated Infection, Health Protection Agency, London, United Kingdom
* To whom correspondence should be addressed. Email:
jane.turton{at}hpa.org.uk.
138 clinical isolates of the Burkholderia cepacia complex (Bcc) were identified using a modified strategy, involving PCR detection of the cblA gene for the ET12 lineage simultaneously with detection of the Bcc recA PCR product, and recA sequence cluster analysis. Four strains could not be assigned to any of the known genomovars.
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
A revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars
![]()
Abstract
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|